Visually significant corneal deposits associated with rifabutin therapy for Bartonella henselae [PDF]
American Journal of Ophthalmology Case ReportsPurpose: To report the clinical and histopathological features of a case of visually significant corneal deposits due to rifabutin therapy used to treat Bartonella henselae.
Ailin Song +2 more
doaj +2 more sources
A Case Series of Rifabutin Use in Staphylococcal Prosthetic Infections
Microbiology Spectrum, 2022 This case series describes seven patients who received rifabutin in place of rifampin combined with conventional antimicrobial therapy for treatment of hardware-associated staphylococcal infections.
Miranda Monk +2 more
exaly +3 more sources
International Journal of Infectious Diseases, 2017 Objectives: The aim of this study was to evaluate whether rifabutin can improve treatment outcomes in patients with rifabutin-sensitive MDR-TB. Methods: A retrospective cohort study was performed on 76 patients with rifabutin-sensitive MDR-TB who were ...
Hyun Lee, Soohyun Ahn, Na Young Hwang
exaly +3 more sources
Superior Efficacy of Bismuth-Containing Rifabutin Quadruple Therapy over Rifabutin Triple Therapy as Salvage Treatment [PDF]
Gut and LiverBackground/Aims : Helicobacter pylori is a pathogen that causes chronic gastritis and peptic ulcer diseases and is a carcinogen responsible for the development of malignancies, including gastric cancer. In the current era of high antimicrobial resistance,
Hannah Lee +4 more
doaj +2 more sources
Pharmacokinetics of rifabutin in Japanese HIV-infected patients with or without antiretroviral therapy. [PDF]
PLoS ONE, 2013 OBJECTIVE: Based on drug-drug interaction, dose reduction of rifabutin is recommended when co-administered with HIV protease inhibitors for human immunodeficiency virus (HIV)-associated mycobacterial infection.
Junko Tanuma +10 more
doaj +1 more source
Pharmacokinetics of rifabutin [PDF]
Antimicrobial Agents and Chemotherapy, 1989 We investigated the pharmacokinetics of rifabutin in 15 male patients as part of a phase I trial of the treatment of early symptomatic human immunodeficiency virus infection. Six or more patients were studied at each of four different oral dosage levels: 300, 600, 900, and 1,200 mg/day.
M H, Skinner +7 more
openaire +2 more sources
Low-dose rifabutin-induced uveitis with premature occurrence: A case series of rare presentation
Indian Journal of Ophthalmology. Case Reports, 2022 Rifabutin is a known-drug prescribed for prophylaxis and treatment of Mycobacterium avium complex (MAC) and causes dose-related anterior uveitis in immunocompromised individuals, particularly, those infected with HIV.
Sumedha Vats +4 more
doaj +1 more source
Severe and disseminated atypical mycobacteriosis of the skin under immunosuppression. [PDF]
J Dtsch Dermatol GesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 6, Page 806-808, June 2026.
Zenderowski V +6 more
europepmc +2 more sources
Ausgeprägte und disseminierte atypische Mykobakteriose der Haut unter Immunsuppression [PDF]
J Dtsch Dermatol GesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 6, Page 806-809, June 2026.
Zenderowski V +6 more
europepmc +2 more sources
Rifabutin-Cobicistat Drug Interaction Resulting in Severe Bilateral Panuveitis
Case Reports in Ophthalmology, 2020 We report a novel case of severe bilateral panuveitis with hypopyon secondary to rifabutin and cobicistat drug interaction in the setting of human immunodeficiency virus (HIV) infection and latent tuberculosis (TB).
Christopher B. Toomey +2 more
doaj +1 more source